Advanced Proteome Therapeutics Corporation

TSXV:APC.H Stock Report

Market Cap: CA$205.6k

Advanced Proteome Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Benjamin Krantz

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure5.8yrs

Recent management updates

Recent updates


CEO

Benjamin Krantz

no data

Tenure

Dr. Benjamin Krantz, MBA, MD, serves as Executive Director of Advanced Proteome Therapeutics Inc. He serves as Director at Advanced Proteome Therapeutics Corporation and serves as its President and Chief E...


Board Members

NamePositionTenureCompensationOwnership
Martin John Woodward
Secretary & Independent Director5.8yrsno data1.33%
CA$ 2.7k
Benjamin Krantz
Presidentno datano datano data
David Webb
Member of Corporate Advisory Board9.6yrsno datano data
William Catalano
Independent Director5.8yrsno data0.75%
CA$ 1.5k
Cory Brandolini
Director1.9yrsno datano data
Paul John Woodward
Director6.5yrsUS$70.28k1.15%
CA$ 2.4k
Greg Thurber
Member of Scientific Advisory Board6.4yrsno datano data
Ravi Chari
Member of Scientific Advisory Board3.3yrsno datano data

5.8yrs

Average Tenure

62yo

Average Age

Experienced Board: APC.H's board of directors are considered experienced (5.8 years average tenure).